Randox Equine Awards NI 2022

Home - Randox Science Park

Randox Equine Awards NI 2022

https://www.linkedin.com/company/107191

Randox Congratulates Manor Equine Vets on winning Best Vet Practice Equine Award 2022

Randox would like to congratulate Manor Equine Vets on winning the Best Vet Practise award at the Randox Equine Awards NI 2022. The Best Veterinary Practise category also included a highly commended award for Oldstone Veterinary Clinic.

Quirine Tettelaar, owner of Manor Equine Vets said “I was very happy to win the award and it was a big surprise! I would like to thank all my lovely clients, friends, and family for their support over the last couple years since starting my business. Hard work and dedication really pays off. It was lovely to read all the comments people left to vote, that was the best part of the awards! I feel really appreciated.”

This event was hosted by Raymond Bready and held at the Titanic Hotel Belfast on Saturday 25th June 2022.

With over 400 guests attending, Randox highlighted the new VeraSTAT-V test which detects the earliest signs of inflammation in horse blood. This stable side test is easy to use and provides quantitative results in six minutes.

Randox testing allows for a healthy horse and healthy rider.

Manor Equine Vets, Quirine Tettelaar and Randox’s Connor Gallagher Celebrate Best Vet Award at The Randox Equine Awards NI 2022

For press enquiries please contact Ellen Watson in the Randox PR team:  randoxpr@randox.com

ABOUT RANDOX

NEWS

VACANCIES

OUR PEOPLE


Biomedical Science Day 2022

Th17 Biochip Array Banner

Biomedical Science Day 2022

Biomedical Science Day is taking place this year on Thursday 9th June 2022. This is an annual celebration to increase the awareness of Biomedical Science and to promote to the public the importance of it.

Biomedical scientists play a key role in diagnosis, quality development and assurance, treatment, research, and development in the modern medical sciences. To celebrate and give recognition we have interviewed one of our RCLS clinical deputy managers, Jayme Hamilton.

 

This is what Jayme has to say about his role in Biomedical Science:

 

 

1. What attracted you to pursue a career in biomedical science?

My degree was in Biological Sciences with Professional Studies. Through it, I was able to design my degree based in my own interests and curiosities, which drew me to exploring the molecular and chemical pathways that elicit biological pathways and also how biotechnology is opening up a future to personalised health and therapies. What I find interesting it how a complete complement of biomarkers needs to be assessed to offer a full illustration of what’s going on under the skin.

2. How many different labs have you worked in?

I have been fortunate to work within several Laboratories to some capacity early in my career. I had a very fulfilling placement within a Method Development and Validation lab at a pharmaceutical company, as well as completing a challenging honours project in population genetics in my final year of university.  Since joining Randox, I have had opportunities to work across several Clinical and Molecular Laboratories with talented colleagues from all sorts of backgrounds; within Liverpool and London in England, Holywood and Antrim in N. Ireland and Los Angeles in California.

 

3. Do you enjoy the practical or theoretical aspect of biomedical science?

Theoretical- I have a drive to learn and understand and thankfully in science that is a continuous journey, as new forms of diagnostics and analysis are born and our understanding can grow or even change.  With a good understanding of the science and a multidisciplinary team of talented individuals to collaborate with, it makes executing the practical work all the more rewarding.

 

4. What is your favourite part of your day in work?

The end of the day -but not why you might think. I have been trying to be more reflective and as the start of the day can be very busy and hands on, I have found it helpful to review my workload and responsibilities, as well as that of those I help lead, at the end of the day; to better look ahead to tomorrow and acknowledge the efforts of the team.

 

5. What’s in your lab coat pocket?

Pens, markers, and more pens. My favourite being my engineering pen, with a torch and stylus included.  Thankfully we push for a more paperless world, but a busy lab can need some quick notes to be made. I’m also a very visual person and find it easiest to communicate to colleagues with notes or even a quick sketch.

 

6. In your opinion, what are the most important aspects of laboratory work?

The results we release. Fundamentally the data we release it for the benefit to the individual they deprived from. By stringently monitoring our quality checks and adhering to the procedures and processes we implement, we can have confidence that the results we release have a high level qualitative and interpretive value.

 

7. In what ways does your work make a difference to people’s lives?

At a personal level, as a clinical deputy manager I aim to optimise and evolve the duties of the colleagues I work with to make their jobs easier and more fulfilling and by extension the functionality of the lab more efficient.

In doing so, I broadly think the work we are doing as a collective, is bringing personalised testing to the masses and in doing so, add to improving the public’s understanding of science, in such that they can begin to take their health into their own hands in a measurable and meaningful way.

 

8. What is your dream career within biomedical science?

Living the dream. So far in my career I have been able to learn and develop within a profession that aligns with my interests, whilst simultaneously contributing to expanding and exciting industry. Throughout which I have had the opportunity to collaborate with many fantastic, talented, intelligent and hardworking people, from an array of disciplines, during the growth of a impressive clinical testing service as well as a nationwide covid testing service.

 

 

 

 

Jayme is a fundamental member of Randox and plays an essential role in the team, as do all our employees. Without our valuable laboratory team working extremely hard behind the scenes the lifesaving work we do here at Randox would not be possible. We thank each one of you for your hard work every day.

To find out more about our Biomedical Science, contact us at market@randox.com

 

Want to know more?

Contact us or visit Biosciences

Contact Us
Visit our Biosciences Page

Lp(a) Calibrator

Lp(a) Control

Lipid EQA Scheme

Reagents Resource Hub


Health Minister Robin Swann visits Randox COVID testing laboratories

COVID-19 Testing        News        Contact Us

20th October 2021: Health Minister Robin Swann visits Randox COVID testing laboratories

Health Minister Robin Swann has today thanked local staff for their ongoing role in COVID-19 testing while visiting Randox Laboratories.

During his visit to the testing facility at Randox Science Park on the outskirts of Antrim, the Health Minister heard how the company significantly increased its testing capacity since the beginning of the pandemic.

Following a tour of the facility, Minister Swann, said: “Randox continues to play an important ongoing role in the fight against COVID-19 as part of the National Testing Programme and has enabled thousands of people in Northern Ireland to get tested quickly.

“There is no doubt, that we are in a very fortunate position in Northern Ireland to have companies like Randox. We have seen how the company and its highly skilled and expert workforce have been able to innovate and advance its testing capabilities to greatly support the pandemic. I want to personally thank the staff at Randox for all they have done in helping to keep people safe.”

Minister Swann added: We are continuing to see a high number of positive cases each day in Northern Ireland which is concerning. Therefore I would again remind people of the importance of getting tested should they develop symptoms. Alongside vaccination and contact tracing, COVID-19 testing remains one of the main pillars of protection against this virus. Please do the right thing.”

Dr Peter FitzGerald, Randox Managing Director said:

“We are delighted to welcome Minister Swann to our COVID testing laboratories at the Randox Science Park in Antrim, to witness first-hand the incredible efforts of our hard-working staff, who have been at the forefront of COVID-19 testing since the outset of the pandemic and as such have played a vital role in the global fight against coronavirus.

“Thanks to their ongoing commitment to serve our communities in these difficult times, Randox remains amongst the very largest COVID-19 laboratories in the UK and Europe, and to date has processed almost 20 million tests for the UK National Testing Programme and testing for international travel.

“Randox have built on 40 years of diagnostic experience, and extensive R&D, to provide our extensive COVID-19 testing capabilities and we will continue to support the community and the needs of travellers for as long as that is required. Thereafter we know that diagnostics have a key role in future healthcare, to both prevent disease and optimise its treatment, and will refocus our efforts to that end.”

Since March 2020, Randox has invested a total of £150 million in the development of new innovations in testing technology and in the building and equipping of world-class testing laboratories, sample collection clinics, and associated logistics networks. The company has also grown its workforce by more than 850, and continues to recruit across science, manufacturing and customer support.

For further information please contact Amy Millar, Randox Public Relations Team Leader; amy.millar@randox.com or 028 9442 2413

Related COVID-19 Products and Services

CERTIFLY LATERAL FLOW

HOME TEST - PCR

ANTIBODY TEST

LABORATORY TOOLS


Randox announces its £30m investment in specialised COVID-19 testing lab

News       About Us       COVID-19

 

03 June 2020

Randox invests £30m and 200 new jobs in specialised COVID-19 testing lab

Randox invests £30m and 200 new jobs in specialised COVID-19 testing lab

As part of efforts to enhance its national testing capacity, global diagnostics company Randox has announced an investment of £30m in a new specialised COVID-19 testing hub.

The healthcare firm, which is currently conducting COVID-19 tests as part of the national testing programme, announced its investment in the new facilities based at the Randox Science Park in Antrim, Northern Ireland, during a visit yesterday by the Secretary of State for Northern Ireland, The Rt Hon Brandon Lewis CBE.

The specialised laboratory, the development of which was fast-tracked over the space of four weeks, is the first step in a wider diagnostics investment programme from Randox.

Dr Peter FitzGerald, Managing Director of Randox Laboratories, commented;

“The national testing programme, as a collaborative effort by government and various partners within industry, has increased testing capacity at an unparalleled speed – by installing a network of drive-through testing centres, introducing home testing kits, and now, opening this specialised lab at the Randox Science Park in Northern Ireland.

“An incredible amount of work has gone into making this cutting-edge testing facility a reality in a relatively short space of time, as we know that effective testing is the most effective way to both save lives and promote a timely return to a more normal society.”

The opening of the new laboratory at the Randox Science Park follows the company’s announcement that it is recruiting new staff across Science, Engineering and Manufacturing in support of its role within the national testing programme.

The 200 new positions will be involved in the testing of potential COVID-19 samples, as well as the construction of 200 new state-of-the-art diagnostic analysers which will significantly increase Randox’s capacity for COVID-19 testing.

Dr FitzGerald continued;

“Now that we have in place the infrastructure and laboratory space required to enhance our testing capacity, we look forward to implementing the next step in our COVID-19 investment programme.

“By accelerating the build schedule for new specialised equipment, and hiring 200 associated workers across Science, Engineering and Manufacturing we will further enhance the government’s national testing scheme, as well as facilitate testing more broadly across the general populace.”

Secretary of State Brandon Lewis MP welcomed the new investment saying:

“I was impressed during my visit with the dedication of staff and the top-class facilities at Randox. This investment will help support the UK’s nationwide effort to fight the coronavirus and ultimately save lives.”  

Dr FitzGerald concluded;

“I would also like to take this opportunity to pay tribute to all my colleagues at Randox who continue to work assiduously to process such a high volume of tests in a timely manner.

“I know I speak on behalf of everyone when I say we appreciate all your hard work and the vital role you play in the practical application of COVID-19 testing.”

    For further information please email randoxpr@randox.com

    Want to know more about Randox?

    Contact us or visit our homepage to view more.

    Our Randox Products and Services

    REAGENTS

    RX SERIES

    ACUSERA

    BIOCHIP


    Randox puts exports under the microscope at NI Chamber Forum

    News       About Us        Careers

    04 September 2019

    NI Chamber Exports Forum

    Putting exports under the microscope at NI Chamber Forum

    The Senior Manager for Government Affairs and Strategic Outreach at Randox, Colonel Mark Campbell CBE will discuss the company’s international success at NI Chamber’s next Exporter Forum on 25 September.

    Supported by Danske Bank, the initiative provides a platform for Northern Ireland’s most successful exporters to share their inspirational journeys in order to encourage others to grow export activity within their own business.

    With offices and distribution in over 145 countries, Randox is one of the region’s most successful exporters and a world leader in the healthcare industry. At the event, Mark will take delegates through the company’s export story, outlining how the business has grown in international markets. Attendees will also be offered an exclusive tour of Randox’s new Science Park.

    Encouraging companies with export aspirations to attend, Jonathan Elder, Corporate Banking Manager at Danske Bank, said:

    “Danske Bank is proud to support the Export First Exporter forum at the brand new Randox Science Park. Randox has for many years been one of Northern Ireland’s most successful export businesses and so the chance to learn from the company’s experience in international markets will, I’m sure, be invaluable for those who attend the event. If we want Northern Ireland’s economy to grow, particularly post-Brexit, it will be essential that more of our small and medium sized businesses follow the example of market leaders like Randox and take the opportunities on offer to them to sell outside of Northern Ireland.”

    Mark Campbell, Senior Manager at Randox Laboratories, added;

    “From the very outset Randox has been focussed on export markets – aiming to improve diagnostics, and healthcare, on a global basis.  After some 37 years, Randox now export to 145 countries and around 95% of our product is exported.

    Pictured: Col. Mark Campbell (Randox), Jonathan Elder (Danske Bank) and Tanya Anderson (NI Chamber)

    “Achieving success in export markets can be challenging but the rewards are potentially significant – both in the potential for growth and in improving overall economic wellbeing.

    “With this focus on exports in mind, we are very much looking forward to the NI Chamber Export First Exporter Forum.  This Forum will provide a valuable opportunity to explore with other Northern Ireland companies export strategies, and how to optimise the potential for company and wider economic growth from overseas markets.

    To register for this event, which takes place on 25 September 2019, between 9.30-11.30am at Randox Laboratories, Antrim visit www.northernirelandchamber.com/events

    Want to know more about Randox?

    Contact us or visit our homepage to view more.

    Our Randox Products and Services

    REAGENTS

    RX SERIES

    ACUSERA

    BIOCHIP


    Randox Sepsis innovation hailed by Health Secretary Matt Hancock

    An innovative new tool for quickly diagnosing the often deadly infection Sepsis, will save lives, the Health Secretary has said.

    The bedside test, being developed by healthcare diagnostics company Randox, will slash the 24 hours usually taken to identify the correct antibiotic for sepsis treatment. Currently, more than a third of those with sepsis die. Every hour that patients are not diagnosed increases the chance of death by 8%.

    Health Secretary Matt Hancock said: “Instead of having to give people huge amounts of antibiotics across the board, which causes other problems, both medical and problems with resistance and super bugs, instead we will be able to work out exactly what the right treatment is for that individual person and do it fast enough to get the treatment in to save lives.”

    He paid a visit to Randox’s new headquarters, the Randox Science Park, in Antrim, Northern Ireland on Thursday 21st March.

    He added: “I can see a very clear application across the health service for how we can use the technology that is being developed here in Northern Ireland, both across the UK and indeed around the world.”

    Sepsis can develop from infections caused by a simple cut or minor medical procedure. The body’s white blood cells fight the infection but the reaction can escalate and also damage healthy tissue.

    Many who survive face amputations because of this tissue damage, Randox’s Molecular Diagnostics Manager Dr Martin Crockard said.

    Dr Crockard highlighted that the traditional sepsis testing method, which involves sending blood samples to laboratories, takes too long. The problem is worsened by the fact that doctors are then forced to initially prescribe broad spectrum antibiotics which are not specific enough for individual patients. This encourages resistant strains.

    To speed up the process, the new technology from Randox’s Biosciences division will allow clinicians in hospital emergency departments to check multiple samples simultaneously, at the press of a few buttons on a smart pad.

    Dr Crockard said it is imperative that appropriate antibiotic treatment is administered as quickly as possible.

    He said: “We can deal with the exact organism causing the problem in less than four hours, allowing you to tailor the treatment for that individual patient very quickly.”

    The UK Sepsis Trust’s Chief Executive Ron Daniels said: “Randox is leading the way around molecular technologies.

    “No other system brings this so close to the clinician on the shop floor.”

    For further information please contact the Randox PR team by emailing randoxpr@randox.com or phoning 028 9442 2413

     

     

     

     

     

     


    £700,000 UK government investment in Randox R&D

    A £700,000 UK Research and Innovation investment into manufacturing processes at Randox means patients could benefit from quicker, cheaper and more consistent diagnosis of diseases.

    The announcement comes exactly one year after the government launched its modern Industrial Strategy – the long-term plan to boost productivity by backing businesses to create high-quality, well-paid jobs in every corner of the United Kingdom.

    The Industrial Strategy Challenge Fund (ISCF) award, administered by UK Research and Innovation (UKRI), will allow Randox Laboratories to further develop its state-of-the-art ‘freeze-drying’ technology which enables the components of vital diagnostic kits to be manufactured, stored and transported more effectively, producing better and speedier diagnoses.

    For the first time it also allows this complicated manufacturing process to be carried out in the UK rather than having to be outsourced to countries such as the United States, bringing more jobs and economic growth. These new genomic analysis tools also have the potential to make a major impact in the global fight against antimicrobial resistance by identifying and quickly sharing information about resistant microbial strains.

    More in-depth analysis of biomarkers in blood and other bodily fluid levels will allow better, quicker diagnosis of cancers and a range of other diseases, ranging from respiratory infections to sepsis, such as blood poisoning.

    The Secretary of State for Northern Ireland said:

    “I am delighted to announce a £700,000k UK Government investment in Randox, a multinational life sciences company in County Antrim. This funding will bring significant benefits to Randox’s vital medical diagnostics and help create well-paid manufacturing jobs in Northern Ireland.

     “A year-on from the launch of our Modern Industrial Strategy, this investment highlights the great progress we are making to boost productivity by backing leading businesses and creating high-quality jobs in every corner of the United Kingdom.”

     John Penrose, Minister of State for Northern Ireland, who visited Randox today to mark the new investment, said:

     “Everyone always says the UK needs more high-tec, high-value added manufacturing and the high-skilled, high-waged jobs it brings. But Randox are actually doing it right here in Northern Ireland. This is properly world leading, cutting-edge industry and I’m delighted that today’s money is helping bring the vision to life.”

    Dr Peter FitzGerald, Managing Director of Randox Laboratories, commented:

    “Innovative diagnostic technologies are not only capable of diagnosing disease and ill-health at the earliest possible stage, but they also have a real potential to advance personalised medicine. Our commitment to developing new and exciting breakthroughs in science, technology, engineering and manufacturing is therefore matched only, by our passion to transform the life of the patient. Randox is leading the way in moving from a one-size-fits-all approach towards decisions, practices, and products tailored to the needs of the individual and the Industrial Strategy Challenge Fund award brings us one step closer to realising that aim.”

    Funded through UK Research and Innovation, the award forms part of the ISCF Early Diagnosis and Precision Medicine programme, focusing on the use of diagnostic information and genetic analysis to drive more personalised healthcare.  Innovate UK, now part of UK Research and Innovation, has supported Randox extensively since 2010, helping grow and scale an innovative diagnostics company who are now distributing their products all over the world.

    The announcement comes after the government’s announcement of the Life Sciences Sector Deal that will support healthcare innovation and back businesses to create high-paid, high-quality jobs as part of the government’s modern Industrial Strategy. The deal signals a vote in confidence in UK industry, with global biopharmaceutical company UCB investing around £1 billion in research and development.

    For further information please contact Randox PR by emailing randoxpr@randox.com 

     

     

     

     

     

     


    We Are Randox | Software Developer Scott McPeake on life in the Randox IT department

    Have you heard about our IT Open Evening on Tuesday 20th November? We’re offering those interested in Software Development, Information Security, Web Design and IT Support the opportunity to have a look around our state-of-the-art IT facilities at the Randox Science Park.

    But as a company known throughout the world for its high-quality health diagnostic products, you may have been surprised to hear that we have such wide-ranging roles available in Information Technology.

    “Randox? Isn’t that just for scientists?” we hear you say.

    We turned to Randox IT Software Developer Scott McPeake for the answer. This is what he said.

    “I imagine if you were to ask my friends from my Computer Science course at university, if they previously knew that Randox offers jobs in IT, they would say no.

    But really, it’s not surprising when you think about it. Technology underpins everything we do in life. Everything is moving digital, and everything digital involves software in some shape or form.

    Even jobs which you assume are predominantly tech-free – let’s say for example, a bus driver – use technology every day. A bus driver relies on technology to administer tickets and to plan their travel routes. It truly is everywhere and it’s only going to expand more.

    Without an innovative IT department, Randox wouldn’t be the successful and reputable company it is today. If there was no IT team, there would be no lab equipment, no websites, no apps. Even organisations who don’t specialise in IT still have it as a core function of the company.

    In the Software Development team, in particular, we design and develop the software used in laboratories to compare results from instruments and samples against other laboratories, to see how these results compare.

    It’s important work, as all our scientists rely on us to be able to do their work in providing blood test results to patients across the world. Our software needs to be operating perfectly to ensure people are getting the correct results and therefore the correct diagnosis. And that’s what makes Randox so reputable.

    Access to technologies

    Being part of a company that is so well established and successful also means that we get exposed to the latest innovations. With IT influencing so much of what we do here, we’re at the forefront of all projects and developments, and are given access to the most up-to-date technologies to make sure we’re providing the best possible products and user experience for our customers, and can stay head of our competitors.

    We’re able therefore to bring to management our ideas about what new software we would like to try, to suggest how it would improve our work. So new software is coming in all the time. I’m currently working with MVC architecture which is a key software framework used widely across the world. It’s definitely something good to get experience in, as is typescript, which although not used as much, is really interesting, and I’ve certainly enjoyed the opportunity to try something new.

    We also work with C# and javascript which are popular, up-to-date products. So whilst the industry of health diagnostics is rather niche, we have the opportunity to use design patterns that are used by most companies, in most industries, to realise our aim of advancing global healthcare.

    And of course, working in Randox, we also get the opportunity to learn about the science of diagnostics, and in particular the machines on which we’re implementing our software designs, which carry out blood testing in hospitals and laboratories. It’s good to challenge yourself to learn something new.

    Teamwork and collaboration

    The chance to expand your knowledge and improve your skills repertoire is probably one of my favourite things about working here at Randox. Everyone works really collaboratively and we help each other out when we need it. So if you don’t know something, no one is going to chastise you. Asking for help and advice is actively encouraged because we each have our own strengths and weaknesses and we can help each other to be a better team. Everyone in the Randox IT team is really willing to help and makes time for you if you need it.

    I remember on my first day here I was really nervous and I arrived at the door unable to get in because it was locked. Someone in the team immediately came to the door, asked me if I was new and welcomed me in to the building. That instantly set the tone. Everyone was really welcoming, friendly and professional.

    And this ability to work together is so crucial. Most days we will be working on the same site but perhaps on different pages so we have to talk to each other to make sure my page doesn’t break theirs and vice versa. Quite often we’ll design the layout of the software collaboratively, and most days we’ll have a morning meeting to discuss our progress.

    If we’re creating something new, we’ll draw up the design based on user requirements and create the software to those designs. Or if an existing site doesn’t work properly, we’ll write up the problem, how to solve it, and then push it up to the production server to fix the bugs.

    Fundamental skills

    So communication is fundamental, as is problem solving.  Being able to keep calm under pressure is also an inherent skill for programming. Deadlines happen; they’re a real thing. You can’t take all day to do something. But it keeps things challenging for us, which is vital, as you don’t want to put your brain to sleep. The work is challenging but solvable, and as I said, you have the team there to help you out and support you.

    We all get on really well and the more experienced software developers in the team have been such great mentors to me. If you’re interested in working in IT I would certainly recommend coming along to our IT Open Evening on Tuesday 20th November so that you can meet all of us and have the opportunity to take a tour of our brand-new facilities in the Randox Science Park.

    Working in Antrim

    The site is really spacious, modern, and easy to get to. For me, coming from Coleraine, I’m just able to get the train to the Antrim station, which is right beside the bus station aswell.

    And Antrim has everything you could need. Shops, supermarkets, nice affordable places to live, and plenty of cafés and restaurants. Sometimes we’ll head out as a team in to Antrim for lunch or dinner together, or if we fancy Belfast, it’s just a short journey on the train.

    So if you’re interested in a dynamic career in software development, take the trip to Antrim to find out a bit more about what Randox has to offer during our Open Evening on 20th November.

    You might not have thought of Randox as a software house but we’re here and we’re working hard to improve healthcare globally!”

    To attend the Randox IT Open Evening on Tuesday 20th November, register for tickets on EventBrite by clicking here.

    For further information please contact the Randox PR team by emailing randoxpr@randox.com or phoning 028 9442 2413

     

     

     

     

     

     


    Randox creates 25 new positions in specialist IT roles in Antrim

    Healthcare diagnostics company Randox has today announced 25 new specialist IT roles ranging from Software Development and Information Security to Web Design and IT Support.

    The roles, which will span a variety of career pathways, including placements, graduates, apprenticeships and permanent positions, will be based at the firm’s new headquarters, the Randox Science Park in Antrim, which will host an IT Open Evening on Tuesday 20th November.

    Those in attendance at the Open Evening will be invited to enjoy a tour of the Randox Science Park, which, following purchase by Randox in 2015, is being developed into a manufacturing and research facility in an investment totalling £161m. The ongoing renovation plans, when complete, will have created a total of 540 high value job opportunities at the site, with an average salary of £30k per year that will generate £16.2 million in annual salaries.

    Stephen Fawl, Randox IT Manager, commented;

    “Working at the cutting edge of technology and innovation, the Randox IT department design and develop a range of web-based applications and software, support the tech infrastructure of more than 1400 employees worldwide, and implement the very latest in security protocols. It’s no surprise therefore that we’re seeking the very best talent to join our team – offering competitive salaries, career progression, personal development and the opportunity to work in an incredibly forward-thinking company. We invite anybody who is interested in a dynamic career in IT to visit us from 6-8pm on the 20th November for our Open Evening at the Randox Science Park.”

    Dr Peter FitzGerald, Managing Director of Randox Laboratories, added;

    “As a global leader in healthcare diagnostics, we must continue innovating, through our people, through our world-class R&D, and through our infrastructure.  With technology heavily influencing so much of what we do, the Randox IT department remain at the forefront of our capability and have a critical role to play in the delivery of cutting-edge innovation. The newly-refurbished IT facilities at the Randox Science Park in Antrim give the team there the platform to engage across a broad range of projects, to make a real and important impact upon global healthcare.”

    Randox, renowned for the placement and employment opportunities it provides students and graduates at both Queen’s University Belfast and Ulster University, has recently launched an ‘Earn As Your Learn’ Higher Level Apprenticeship in Computing, with Northern Regional College.

    Through the ‘Career Encode’ programme, Randox is offering three-year apprenticeship vacancies in the IT department, in addition to a range of senior roles for the more experienced IT professional. The apprenticeship scheme is equivalent to a foundation degree and provides a clear progression route for apprentices to train to the highest level whilst gaining a professional qualification.

    Councillor Paul Michael, Mayor of Antrim and Newtownabbey, commented;

    “The creation of these specialist IT jobs for the Antrim community, as a direct result of Randox’s ongoing investment and expansion is further proof, if needed, of their commitment to the regional economy. To be able to offer both experienced and aspiring IT professionals, whether students, graduates or full-time IT specialists, the opportunity to work in such high-calibre roles so close to home is an incredibly unique opportunity and I look forward to welcoming new IT staff to the fantastic Randox Science Park facilities.”

    Randox Laboratories currently employ 1400 employees globally, 800 of which are based in its Northern Ireland sites in Crumlin and Antrim.

    Register your interest for the Randox IT Open Evening by collecting your free tickets here.

    For further information about the Randox IT Open Evening, please contact Randox PR by emailing randoxpr@randox.com or phoning 028 9442 2413.

     

    Randox IT Manager Stephen Fawl and Senior Recruitment Consultant Lyndsay Rodgerson are pictured with Councillor Paul Michael, Mayor of Antrim and Newtownabbey, at the launch of Randox’s 25 new specialist IT roles

     

     


    £50m Randox Centres of Excellence launched in Northern Ireland

    A record £50 million investment which will deliver cutting-edge technologies to diagnose conditions like cancer, heart conditions and infectious diseases has been announced by Northern Ireland diagnostics company Randox Laboratories and Invest Northern Ireland.

    This major project involves the establishment of three Centres of Excellence, enabling Randox R&D scientists to work collaboratively with colleagues from Queen’s University Belfast and Ulster University. The centres are being officially launched today at the Randox Science Park. The ceremony will include a keynote address from Sir John Bell, who chaired the UK Government’s Life Sciences Industrial Strategy Board.

    Advanced diagnostics have been identified as key to delivering sustainable improvement to healthcare systems struggling to cope with increasing levels of chronic and preventable conditions. Having been focused in this field for over 36 years, Randox has a successful track record of developing new and innovative tests – examples include assessing those at risk of Alzheimer’s disease and genetic cardiac conditions, to promote and enable preventive treatment, and a new clinically-approved test to diagnose prediabetes.

    Managing Director of Randox Laboratories, Dr Peter FitzGerald, who today launched the three Centres of Excellence, said;

     “When almost a quarter of the deaths of people under 75 in the UK are considered preventable, we need to ask ourselves what can be done to improve healthcare outcomes. There is an undeniable case for radical change in the way healthcare is delivered, and sophisticated diagnostics will be at the fore of this revolution.

    “Enabling earlier and more accurate diagnosis, to identify those at the earliest stages of illness, ideally before the onset of any symptoms, is a game-changer. Through early intervention we can restrict the development of chronic conditions and improve people’s lives. Our view of the future is one where people are empowered through earlier diagnosis to stay healthier for longer, and where healthcare systems are freed to deliver quality services to patients. Our announcement today demonstrates our continuing commitment in this field.

    “We are grateful for the support offered by Invest NI and look forward to addressing these pressing healthcare needs.”

    The Centres of Excellence will focus respectively on clinical diagnostics, engineering for biosciences and quality control. The project, which will strengthen collaborative partnerships between Randox, Queen’s University Belfast and Ulster University, will accelerate the development of new technologies and drive healthcare improvements regionally, nationally and across the globe.

    Of the £23m of support offered by Invest NI, £5m will go toward research projects at Ulster University and Queen’s University Belfast.

    Welcoming the investment, Alastair Hamilton, Chief Executive of Invest NI said;

    “Randox has a long history of investing heavily in innovation and R&D which has enabled it to create a globally competitive export driven business, capable of developing world leading research. This major investment will enable Randox to perform cutting-edge R&D which has the potential to revolutionise the global healthcare industry. This is excellent news for Northern Ireland’s life and health sciences sector. Northern Ireland is enjoying a growing international reputation as a region of expertise and knowledge in key areas such as Diagnostics, Precision Medicine and Advanced Manufacturing. The three new Centres of Excellence will help build on this and enhance Northern Ireland’s credibility, provide supply chain opportunities, and encourage knowledge transfer with our universities.”    

    Sir John Bell, commenting on the potential for the UK Life Sciences sector said;

    “The life sciences industry represents one of the dominant economic sectors in the UK, and one with considerable potential for growth.   However, whilst we have many natural strengths we cannot afford to be complacent.  We must strive to optimise our science base, to encourage collaboration across academia, industry and the NHS, and grow our industrial capabilities.  To do so we need to use our extensive data sets to best effect, and have in place a strong skills strategy.  Success requires vision and drive.  To that end I would like to congratulate Dr FitzGerald and Randox in the establishment of these three R&D collaborative Centres of Excellence – these are assets of national standing and will have a meaningful impact in enabling earlier and more accurate diagnosis, driving improvements in patient care, regionally, nationally and globally.  They are leaders in this field, committed to innovation, and I wish them every success.”

    Professor Jim McLaughlin, Director of Ulster University’s Nanotechnology and Integrated Bioengineering Centre, added;

    “This very welcome investment enables pioneering Randox-inspired engineering capacity at Ulster University and reflects our research commitment to the life sciences industry. From nanotechnology to the development of systems that will enable large scale laboratory capability to be produced in the palm of your hand, the partnership brings shared industry and academic research excellence from the lab into the marketplace. Life sciences is a vital economic sector locally and this collaboration will advance diagnostics and ultimately enhance patient health outcomes.”

    Dr David Jess, Senior Lecturer at Queen’s University Belfast School of Mathematics and Physics, added;

    “The Randox Centres of Excellence will allow Queen’s University Belfast to continue to deliver cutting-edge and world leading research. We look forward to collaborating further with industry to develop pioneering research, focused on the needs of society.”

    Invest NI’s R&D support is part funded by ERDF under the EU Investment for Growth and Jobs Programme 2014 – 2020.

    For further information please contact the Randox PR Team: phone 028 9442 2413 or email randoxpr@randox.com 

     


    Request a meeting
    ×
    Make an Enquiry - RX series
    ×
    Make an Enquiry - Reagents
    ×
    Kit Insert Request - Reagents
    • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
    ×
    Kit Insert Request - Reagents
    • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.